The role of cardiorenal biomarkers for risk stratification in the early follow-up after hospitalisation for acute heart failure

Field Value
Model ID13-103-01
Model NameTolonen 2013
Pubmed ID23879546
First AuthorTolonen
JournalBiomarkers
Year2013
TitleThe role of cardiorenal biomarkers for risk stratification in the early follow-up after hospitalisation for acute heart failure
Primary Index ConditionChronic Heart Failure (CHF)
Secondary Index ConditionN/A
OutcomeComposite
Model Sample Size124
Cohort Sample Size124
Number of Events33
Follow-Up DurationModerate (3-6 months)
AUROC0.70
Calibration Reported1
CovariatesW5 NT-proBNP Q4 (>=4972 pg/ml), W5 cystatin >= median (1.33 mg/l), Lack of >=30% decrease in NT-proBNP, W5 troponin I positivity (>=0.035 ug/l)
Mesh TermsTo be updated
Number of Validations0

External Validations